Symbol="MRUS"
AssetType="Common Stock"
Name="Merus BV"
Description="Merus NV, a clinical-stage immuno-oncology company, is dedicated to the discovery and development of bispecific antibody therapies in the Netherlands. The company is headquartered in Utrecht, the Netherlands."
CIK="1651311"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="YALELAAN 62, 3584 CM UTRECHT, NL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1250530000"
EBITDA="-170620000"
PERatio="None"
PEGRatio="0"
BookValue="5.16"
DividendPerShare="0"
DividendYield="0"
EPS="-4.01"
RevenuePerShareTTM="0.883"
ProfitMargin="0"
OperatingMarginTTM="-4.184"
ReturnOnAssetsTTM="-0.267"
ReturnOnEquityTTM="-0.611"
RevenueTTM="41222000"
GrossProfitTTM="-107838000"
DilutedEPSTTM="-4.01"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.174"
AnalystTargetPrice="46.44"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.19"
PriceToBookRatio="2.148"
EVToRevenue="6.65"
EVToEBITDA="-2.372"
Beta="0.808"
num_52WeekHigh="27.7"
num_52WeekLow="12.03"
num_50DayMovingAverage="24.98"
num_200DayMovingAverage="19.85"
SharesOutstanding="57695000"
DividendDate="None"
ExDividendDate="None"
symbol="MRUS"
open="22.33"
high="22.51"
low="20.44"
price="21.74"
volume="104461.00"
latest_trading_day="2023-08-28"
previous_close="22.32"
change="-0.58"
change_percent="-2.5986%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="8"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="92"
Volume_recent_avg="362294"
Change_recent_avg="-0.03"
Delta_recent_avg="1.28"
Variance_recent_avg="0.64"
Change_ratio_recent_avg="-0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="92"
Aroon_momentum_negative="8"
image_negative_thumbnail_id_1="1107"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0140.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="543"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="628"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0080.jpeg"
image_positive_thumbnail_id_2="652"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0056.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
